WisdomTree Emerging Markets Efficient Core Fund
NTSE
New York Stock Exchange Arca- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management - Global
- Address
- 250 West 34th Street, 3rd Floor New York NY United States of America 10119
- IPO Date
- May 20, 2021
- CIK
- 0001350487
- Website
- wisdomtree.com
- Similar Companies
- Business
- WisdomTree Emerging Markets Efficient Core Fund (NTSE) is an actively managed exchange-traded fund that seeks total return through investments in emerging markets equity securities and U.S. Treasury futures contracts; it allocates approximately 90% of its assets to a representative basket of emerging market equities generally weighted by market capitalization, while using derivatives such as laddered U.S. Treasury futures to create an effective 60% bond exposure for enhanced capital efficiency and potential volatility reduction. The fund provides exposure to large-cap (89%), mid-cap (11%), and small-cap emerging market companies across diversified sectors; key country allocations include China (14%), Taiwan (11%), India (7%), South Korea (5%), and South Africa (3%), with top holdings concentrated in high-market-cap firms. Launched on May 20, 2021, and domiciled in the United States, NTSE operates primarily in U.S. markets while targeting emerging market equities globally, including regions such as Emerging Asia, Latin America, Africa, and Emerging Europe; it is issued by WisdomTree Trust and managed by WisdomTree Asset Management, Inc., with sub-advisors including Mellon Investments Corporation. The fund maintains an expense ratio of 0.32%, with total assets under management of approximately $32 million and shares outstanding of 950,000 as of mid-2025; it benchmarks performance against the MSCI Emerging Markets Index and emphasizes overlay strategies correlated to common portfolio benchmarks. Recent portfolio adjustments reflect ongoing active management, including share changes in holdings such as Samsung Biologics as of December 1, 2025, alongside routine rebalances aligned with WisdomTree's broader index methodologies. No major acquisitions, funding rounds, or structural reorganizations have been reported for NTSE in the last 1-2 years; it continues as part of WisdomTree's Efficient Core suite launched in May 2021, supporting investor demand for diversified emerging markets exposure with fixed-income overlays.